Scientific Programme
387
Wednesday
Thursday
friday
Saturday
Young Academy
Q & A Modul
FV-021
Oral Presentations
10.15– 11.45 h
|
Salon 17/18
Topic 8:
Disorders closely related to
childhood and adolescence, F7-9
Disorders in relation to childhood and
youth
Chairs: Christine M. Freitag, Frankfurt am
Main (Germany)
Beate Herpertz-Dahlmann, Aachen
(Germany)
001
Dialectical behaviour therapy for ad-
olescents – an inpatient therapy concept
for adolescents with emotion regulation
disorder and borderline-specific symp-
tomatology
Andrea Dixius, Idar-Oberstein (Germany)
Eva Möhler
002
The role of media in shaping sexual
disorders in youth
Tatiana Butkova, Moscow (Russia)
003
Methylphenidate improves hand-
writing of children with ADHD – a
systematic review of controlled clinical
trials
Meisam Ghanbari, Shiraz (Iran)
Ahmad Ghanizadeh
004
Association of childhood trauma
and low hair cortisol
Kim Hinkelmann, Berlin (Germany)
Christoph Muhtz, Lucia Dettenborn,
Agorastos Agorastos, Katja Wingenfeld,
Carsten Spitzer, Wei Gao, Clemens
Kirschbaum, Klaus Wiedemann, Christian
Otte
005
National Total Survey of German
adolescent suicide in prison
Daniel Radeloff, Frankfurt am Main
(Germany)
Thomas Lempp, Mattias Kettner, Katharina
Bennefeld-Kersten, Christine M. Freitag
006
The impact of olfactory cues on
social cognition: implications for autism
spectrum disorders
Olga Wudarczyk, Aachen (Germany)
PL-003
Plenary Session
12.00– 13.00 h
|
Hall 2
D
U
E
Topic 13:
Neurobiology, neurogenetics,
epidemiology
Social and biological foundations of
fairness
Chairs: Peter Falkai, Munich (Germany)
Andreas Meyer-Lindenberg,
Mannheim (Germany)
001
Award ceremony: DGPPN Doctoral
Thesis Award – Hans-Heimann Award
Peter Falkai, Munich (Germany)
002
Social and biological foundations of
fairness
Ernst Fehr, Zürich (Switzerland)
B-015
Special Session
13.30– 15.00 h
|
Hall 3
E
U
D
Topic 15:
Pharmacotherapy
Presidential Debate: arising questions on
antidepressant therapy
Chairs: Eckart Rüther, Feldafing (Germany)
Thomas E. Schläpfer, Bonn
(Germany)
001
Antidepressants: are the benefits
worth the risks?
Irving Kirsch, Hull (United Kingdom)
002
Pharmacological treatment of de-
pression: a remarkable success story
Elias Eriksson, Gothenburg (Sweden)
003
Antidepressants: clinical problems
and research realities
David Healy, Cardiff (United Kingdom)
004
The important role of antidepres-
sants in the treatment of depression:
research problems and clinical reality
Hans-Jürgen Möller, Munich (Germany)
